Patterson-UTI’s earnings were impacted by impairments but still shows strong cash flow. Find out why PTEN stock is a BUY with ...

In a report released today, Atidrip Modak from Goldman Sachs maintained a Buy rating on Patterson-UTI (PTEN – Research Report), with a price ...

A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response critical for their elimination.

Patterson-UTI Energy (PTEN) has disclosed a new risk, in the Technology category. Patterson-UTI Energy is currently facing potential business ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.